Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) is now available.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced a final cash dividend of RMB 0.4 per share for the financial year ending December 31, 2024. The dividend will be paid in Hong Kong dollars at a rate of HKD 0.4362 per share, with a payment date set for July 18, 2025. The announcement includes details on withholding tax rates applicable to different categories of shareholders, impacting both resident and non-resident stakeholders. This move reflects the company’s financial health and commitment to returning value to its shareholders.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$25.40 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is known for its range of traditional Chinese medicines and modern pharmaceuticals, catering to both domestic and international markets.
Average Trading Volume: 1,388,448
Technical Sentiment Signal: Sell
Current Market Cap: HK$45.22B
For a thorough assessment of 0874 stock, go to TipRanks’ Stock Analysis page.